Home Carboxys 9H-Pyrido[3,4-b]indole-3-carboxylicacid, ethyl ester

9H-Pyrido[3,4-b]indole-3-carboxylicacid, ethyl ester

CAS No.:
74214-62-3
Catalog Number:
AG008QS3
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.2573
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
97%
1 week
United States
$94
- +
Product Description
Catalog Number:
AG008QS3
Chemical Name:
9H-Pyrido[3,4-b]indole-3-carboxylicacid, ethyl ester
CAS Number:
74214-62-3
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.2573
MDL Number:
MFCD00009730
IUPAC Name:
ethyl 9H-pyrido[3,4-b]indole-3-carboxylate
InChI:
InChI=1S/C14H12N2O2/c1-2-18-14(17)12-7-10-9-5-3-4-6-11(9)16-13(10)8-15-12/h3-8,16H,2H2,1H3
InChI Key:
KOVRZNUMIKACTB-UHFFFAOYSA-N
SMILES:
CCOC(=O)c1ncc2c(c1)c1ccccc1[nH]2
UNII:
HYW8K5N21Y
NSC Number:
610937
Properties
Complexity:
321  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
240.09g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
240.262g/mol
Monoisotopic Mass:
240.09g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
55A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9  
Literature
Title Journal
Remarkable selectivity of the in vivo binding of [3H]Ro15-4513 to α5 subtype of benzodiazepine receptor in the living mouse brain. Synapse (New York, N.Y.) 20101201
Alcohol- and alcohol antagonist-sensitive human GABAA receptors: tracking δ subunit incorporation into functional receptors. Molecular pharmacology 20101101
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse. Bioorganic & medicinal chemistry 20101101
Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats. Behavioural pharmacology 20090201
3D and quantum QSAR of non-benzodiazepine compounds. European journal of medicinal chemistry 20081101
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit. Journal of medicinal chemistry 20080710
Efficacy and the discriminative stimulus effects of negative GABAA modulators, or inverse agonists, in diazepam-treated rhesus monkeys. The Journal of pharmacology and experimental therapeutics 20060801
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Negative GABA(A) modulators attenuate the discriminative stimulus effects of benzodiazepines and the neuroactive steroid pregnanolone in rhesus monkeys. Psychopharmacology 20051001
Identification of a residue in the gamma-aminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding. Journal of neurochemistry 20040301
The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues. Journal of medicinal chemistry 20031009
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. Journal of medicinal chemistry 20000113
Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors. Journal of medicinal chemistry 19980702
Increasing-current electroshock seizure test: a new method for assessment of anti- and pro-convulsant activities of drugs in mice. Journal of pharmacological and toxicological methods 19960201
Enhanced sensitivity to beta-carboline inverse agonists in rats chronically treated with FG 7142. Brain research bulletin 19870901
Chlordiazepoxide enhances the anxiogenic action of CGS 8216 in the social interaction test: evidence for benzodiazepine withdrawal? Pharmacology, biochemistry, and behavior 19850701
Isoniazid-induced convulsions in rats: effects of Ro 15-1788 and beta-CCE. European journal of pharmacology 19850619
Evidence for an involvement of GABA receptors in the mediation of the proconvulsant action of ethyl-beta-carboline-3-carboxylate. Neuropharmacology 19840301
Properties